GO
Loading...

Bristol-Myers Squibb Co

More

  • Final Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 6:01 PM ET

    Baxter International Inc. rose$. 71 or 1.0 percent, to $68.65. Bristol-Myers Squibb Co. rose $1.39 or 2.7 percent, to $51.95. Hospira rose $1.01 or 2.0 percent, to $50.88.

  • Midday Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 1:43 PM ET

    Baxter International Inc. rose$. 28 or. 4 percent, to $68.22. Bristol-Myers Squibb Co. rose$. 81 or 1.6 percent, to $51.37. Hospira rose$. 24 or. 5 percent, to $50.11.

  • Early Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 11:56 AM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $68.01. Bristol-Myers Squibb Co. rose$. 42 or. 8 percent, to $50.98. Hospira rose$. 22 or. 4 percent, to $50.09.

  • Final Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 6:05 PM ET

    Baxter International Inc. rose$. 70 or 1.0 percent, to $67.94. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $50.56. Hospira fell$. 20 or. 4 percent, to $49.87.

  • Midday Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 1:23 PM ET

    Baxter International Inc. rose$. 18 or. 3 percent, to $67.42. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $50.25. Hospira fell$. 18 or. 4 percent, to $49.89.

  • Early Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 10:40 AM ET

    Baxter International Inc. rose$. 02 or percent, to $67.26. Bristol-Myers Squibb Co. rose$. 03 or. 1 percent, to $50.45. Hospira rose$. 25 or. 5 percent, to $50.32.

  • Final Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 94 or 1.4 percent, to $67.24. Bristol-Myers Squibb Co. rose $1.20 or 2.4 percent, to $50.42. Hospira rose$. 40 or. 8 percent, to $50.07.

  • Midday Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 1:21 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $67.83. Bristol-Myers Squibb Co. rose $1.49 or 3.0 percent, to $50.71. Hospira rose$. 36 or. 7 percent, to $50.03.

  • Early Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 10:39 AM ET

    Baxter International Inc. fell$. 47 or. 7 percent, to $67.71. Bristol-Myers Squibb Co. rose$. 49 or 1.0 percent, to $49.71. Hospira fell$. 19 or. 4 percent, to $49.48.

  • Final Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $68.18. Bristol-Myers Squibb Co. rose$. 26 or. 5 percent, to $49.22. Hospira rose $1.55 or 3.2 percent, to $49.67.

  • Midday Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 1:21 PM ET

    Baxter International Inc. rose$. 65 or 1.0 percent, to $68.99. Bristol-Myers Squibb Co. rose$. 30 or. 6 percent, to $49.26. Hospira rose$. 61 or 1.3 percent, to $48.73.

  • Early Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 11:35 AM ET

    Baxter International Inc. fell $1.01 or 1.5 percent, to $67.33. Bristol-Myers Squibb Co. rose$. 25 or. 5 percent, to $49.21. Hospira rose$. 32 or. 7 percent, to $48.44.

  • Final Glance: Pharmaceuticals companies Wednesday, 15 Oct 2014 | 6:07 PM ET

    Baxter International Inc. fell$. 52 or. 8 percent, to $68.34. Bristol-Myers Squibb Co. rose$. 04 or. 1 percent, to $48.96. Eli Lilly& Co. fell$. 27 or. 4 percent, to $62.87.

  • The first, Esbriet, was developed by InterMune Inc, which Switzerland- based Roche Holding AG agreed to buy for $8.3 billion in August, banking largely on the treatment's potential. The agency's decision marks a crucial milestone in the management of the disease, which affects about 100,000 people in the United States. Roche's drug, known generically as...

  • Midday Glance: Pharmaceuticals companies Wednesday, 15 Oct 2014 | 1:17 PM ET

    Baxter International Inc. fell $1.69 or 2.5 percent, to $67.17. Bristol-Myers Squibb Co. fell$. 57 or 1.2 percent, to $48.35. Hospira fell $1.32 or 2.7 percent, to $47.00.

  • Early Glance: Pharmaceuticals companies Wednesday, 15 Oct 2014 | 10:46 AM ET

    Baxter International Inc. fell $1.10 or 1.6 percent, to $67.76. Bristol-Myers Squibb Co. fell$. 64 or 1.3 percent, to $48.28. Hospira fell$. 37 or. 8 percent, to $47.94.

  • ConvaTec owners appoint banks to explore sale - sources Wednesday, 15 Oct 2014 | 6:17 AM ET

    LONDON, Oct 15- ConvaTec's owners have appointed Morgan Stanley and Goldman Sachs to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said. Private equity firms Avista Capital Partners and Nordic Capital are preparing the groundwork for a possible sale or initial public offering in 2015 for the...

  • Final Glance: Pharmaceuticals companies Tuesday, 14 Oct 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 80 or 1.1 percent, to $68.86. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $48.92. Hospira fell$. 04 or. 1 percent, to $48.31.

  • Midday Glance: Pharmaceuticals companies Tuesday, 14 Oct 2014 | 1:42 PM ET

    Baxter International Inc. rose$. 01 or percent, to $69.67. Bristol-Myers Squibb Co. rose$. 03 or. 1 percent, to $49.12. Hospira rose$. 43 or. 9 percent, to $48.78.

  • Early Glance: Pharmaceuticals companies Tuesday, 14 Oct 2014 | 10:27 AM ET

    Baxter International Inc. rose$. 02 or percent, to $69.68. Bristol-Myers Squibb Co. fell$. 13 or. 3 percent, to $48.96. Hospira fell$. 04 or. 1 percent, to $48.31.